BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 337565)

  • 1. Synergism between platelet aggregating agents: the role of the arachidonate pathway.
    Kinlough-Rathbone RL; Packham MA; Mustard JF
    Thromb Res; 1977 Nov; 11(5):567-80. PubMed ID: 337565
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187.
    Kinlough-Rathbone RL; Packham MA; Reimers HJ; Cazenave JP; Mustard JF
    J Lab Clin Med; 1977 Oct; 90(4):707-19. PubMed ID: 333044
    [No Abstract]   [Full Text] [Related]  

  • 3. Cadmium-induced platelet hypersensitivity to aggregating agents.
    Caprino L; Togna G; Togna AR
    Pharmacol Res Commun; 1979 Oct; 11(9):731-7. PubMed ID: 231263
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
    Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
    Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin.
    Tandon NN; Ordinas A; Jamieson GA
    Biochim Biophys Acta; 1982 Nov; 719(2):388-95. PubMed ID: 6817815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-tocopherol: its inhibition on human platelet aggregation.
    Fong JS
    Experientia; 1976 May; 32(5):639-41. PubMed ID: 1278322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of prostaglandins in the ADP-induced aggregation of rabbit platelets shown by the use of 15-hydroxyprostaglandin dehydrogenase.
    Wallis RB
    Thromb Haemost; 1978 Jun; 39(3):725-32. PubMed ID: 705701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom.
    Teng CM; Ma YH; Ouyang CH
    Biochim Biophys Acta; 1985 Jul; 841(1):8-14. PubMed ID: 3926005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of tris on responses of human and rabbit platelets to aggregating agents.
    Packham MA; Guccione MA; Nina M; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1984 Apr; 51(2):140-4. PubMed ID: 6429880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of heparin on platelet aggregation in vitro].
    RĂ³ka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of PGI2 on platelet aggregation induced by various stimulants.
    Ohtsu A; Hoshina K; Kurozumi S; Hashimoto Y; Noguchi T; Nicolaou KC
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):659-66. PubMed ID: 388963
    [No Abstract]   [Full Text] [Related]  

  • 14. Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom.
    Teng CM; Chen YH; Ouyang C
    Biochim Biophys Acta; 1984 May; 772(3):393-402. PubMed ID: 6426517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Platelet aggregation induced by arachidonic acid, ADP, thrombin. Study of the antiaggregation effects of verbenone and indomethacin].
    Chiariello M; Campana G; Delfanti G; Capuano D
    Boll Chim Farm; 1986 Nov; 125(11):387-9. PubMed ID: 3109452
    [No Abstract]   [Full Text] [Related]  

  • 16. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.
    Sturk A; Asyee GM; Schaap MC; van Maanen M; ten Cate JW
    Thromb Res; 1985 Nov; 40(3):359-72. PubMed ID: 2934863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XC 386: a new antiplatelet agent.
    Wang JP; Hsu MF; Tsai HY; Huang LJ; Teng CM
    Thromb Res; 1984 Oct; 36(2):113-22. PubMed ID: 6438827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite effect of lysine on platelet aggregation induced by arachidonate and by other aggregants.
    Ts'ao C; Hart SJ; Krajewski DV; Sorensen PG
    Thromb Haemost; 1982 Aug; 48(1):78-83. PubMed ID: 6813998
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of platelet aggregation by novel benzoylpyrrole derivatives.
    Kurozumi S; Ohtsu A; Hoshina K; Jimba M; Komoriya K; Naruchi T; Wakabayashi T; Hashimoto Y; Ishimoto S
    Adv Prostaglandin Thromboxane Res; 1980; 6():305-7. PubMed ID: 7386272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.